Patients with established type 2 diabetes treated with one to three OADs In patients with established type 2 diabetes already receiving one or two OADs, both oral and injection semaglutide demonstrated significant weight reductions compared to the respective comparators
Patients who need immediate treatment while the PA is being processed can ask their prescriber about a short-term generic stimulant bridge prescription, which typically does not require PA on Aetna plans
If you are using compounded semaglutide in a vial (which is not FDA-approved), follow your pharmacy's specific instructions
If you prefer oral delivery, PlexusDx offers compounded oral semaglutide at $289/mo (or $249/mo on the 6-month plan), and your prescriber can monitor your response through weight loss and metabolic markers to confirm adequate absorption
Radenkovic, D., Reason, & Verdin, E